Publications by authors named "Supadmanaba I"

Objectives: This study aimed to determine the expression of CD44 in breast cancer and its association with patients' clinicopathological data, particularly in Bali.

Material And Methods: This was a cross-sectional study in the Integrated Biomedical Laboratory and Biochemistry Laboratory of the Faculty of Medicine Udayana University, during January-December 2022, which lasted 12 months with 46 samples.

Results: The study showed that the age range of our subjects was 38-86 years old, with the majority of the parity being less than three.

View Article and Find Full Text PDF

Pancreatic ductal adenocarcinoma (PDAC) poses significant challenges in terms of prognosis and treatment. Recent research has identified splicing deregulation as a new cancer hallmark. Herein, we investigated the largely uncharacterized alternative splicing profile and the key splicing factor SF3B1 in PDAC pancreatic cells and tissues as a potential discovery source of plausible drug targets and new predictive biomarkers of clinical outcome.

View Article and Find Full Text PDF

Objective: This study aimed to investigate the level of PD-L1 protein expression in patients with BCs who were of Asian descent.

Methods: Three databases were conducted on this article up to August 10th, 2022. The reference lists of the publications were examined for further studies, and in cases of duplicates, a study with a larger sample size was added.

View Article and Find Full Text PDF

Diabetes mellitus (DM) is still a challenging metabolic disease worldwide. In the current situation, the world is facing a COVID-19 pandemic due to SARS-CoV-2 infection. DM is one of the comorbid conditions that can worsen the severity of the COVID-19 condition.

View Article and Find Full Text PDF

Objectives: This meta-analysis aimed to evaluate the association between USP39 expression, the prognosis of patients with solid cancer, and to identify the clinicopathological characteristics of these patients.

Material And Method: This study was carried out using PRISMA strategy. Pubmed, ScienceDirect, Google Scholar, Ebsco, Cochrane Library electronic databases were searched for relevant studies published up to April 2022.

View Article and Find Full Text PDF

Background: C-X-C Motif Chemokine Receptor (CXCR4) is an oncogene that widely studied and associated with worse clinicopathological features and prognosis outcome on many types of cancer. Beside that, significance of CXCR4 expression on clinicopathological features and prognostic on osteosarcoma (OS) require further validation.

Aim: We conducted a meta-analysis to evaluate association between positive CXCR4 expression with clinicopathological features, and prognosis in OS.

View Article and Find Full Text PDF

Objective: Molecular based predictive biomarkers have been developed but still unaffordable in developing countries. The leukocyte ratio is known as a promising, affordable and practical biomarker. However, the evidence to support their application is still lacking, especially from developing countries.

View Article and Find Full Text PDF

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers because of diagnosis at late stage and inherent/acquired chemoresistance. Recent advances in genomic profiling and biology of this disease have not yet been translated to a relevant improvement in terms of disease management and patient's survival. However, new possibilities for treatment may emerge from studies on key epigenetic factors.

View Article and Find Full Text PDF

: Recent studies suggested that extracellular vesicles (EVs) play a role both in the metastatic niche formation and in the progression of several tumors, including pancreatic cancer. In particular, the effects of EVs on metastasis should be studied in model systems that take into account both the tumor cells and the metastatic site/tumor microenvironment. Studies with labeled EVs or EV-secreting cells in models will reflect the physiological and pathological functions of EVs.

View Article and Find Full Text PDF
Article Synopsis
  • Cancer metastasis starts when tumor cells spread from the original tumor, relying on metabolic changes for growth and survival, particularly via a process called aerobic glycolysis, or the Warburg effect.
  • This process involves faster glucose oxidation, which leads to more lactate production and influences the immune response, while surrounding cells enhance the metastasis-promoting features.
  • Targeting glycolysis with therapies like LDH-A inhibitors shows promise against various cancers, potentially leading to less toxic treatments and improved outcomes when combined with agents like vitamin C to further impede cancer cell survival and invasion.
View Article and Find Full Text PDF

Background: To optimize the preventive measures of malaria, it is important to synchronize the efforts with the behavior of local species. However, the data of species and their behavior in Indonesia is still lacking.

Method: Explorative research was conducted from April to September 2016 in Southern Minahasa district.

View Article and Find Full Text PDF